Education News and Research

RSS

WARRIOR trial finds no impact of intensive therapy on heart events in women

An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events at five years in women who experienced signs and symptoms of ischemia, or insufficient blood flow to the heart muscle, but had no blockages in their heart's arteries, according to research presented at the American College of Cardiology's Annual Scientific Session.

29 Mar 2025

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major bleeding, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes in the first-of-its kind trial to evaluate the use of a GLP-1 agonist to manage PAD.

29 Mar 2025

Study finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was significantly more effective and caused fewer adverse effects than frozen plasma, the standard therapy, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Research reveals optimal duration of dual antiplatelet therapy after stent implantation

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure.

29 Mar 2025

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of low-dose apixaban, experienced similar VTE recurrences and less bleeding as similar patients who received a full dose of the oral blood-thinning medication over the same extended period.

29 Mar 2025

Rivaroxaban shown to be a viable alternative to warfarin for left ventricular thrombus

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard treatment with warfarin, an older blood-thinning drug.

29 Mar 2025

The Giants Foundation and American Heart Association promote life-saving CPR skills

The American Heart Association and The Giants Foundation, the nonprofit organization of the New York Giants, gathered representatives from 12 local schools for cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) training on March 20 at MetLife Stadium.

28 Mar 2025

UTA expert discusses the latest developments of measles outbreak in Texas

Measles is a highly contagious disease that was declared eliminated from the U.S. by the World Health Organization 25 years ago due to the success of vaccination efforts.

28 Mar 2025

A briefing on the impact of obesity in older populations

GSA is a professional membership organization committed to promoting the best available interdisciplinary aging research to advance innovations in practice and policy. This is especially key to managing the chronic condition of obesity in health care.

28 Mar 2025

Discrimination exposure found to raise anxiety, depression risks among racial and ethnic groups

A new study found that more than half of US adults encounter some form of discrimination, and that this mistreatment may fuel higher chances of depression and/or anxiety among specific racial and ethnic groups due to cultural, social, and systemic factors.

28 Mar 2025

Interval cancers account for significant breast cancer cases

In a new study, researchers from Karolinska Institutet have shown that so-called interval cancers, which are detected between two screening sessions, account for a significant proportion of breast cancer cases and that certain risk factors may increase the likelihood of developing this type of cancer.

28 Mar 2025

Expanded access to anti-obesity medications could boost life expectancy and save society billions

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a substantial societal return on investment, even after accounting for treatment costs.

27 Mar 2025

Banning smartphone and social media access fails to protect children from digital harm

Banning smartphone and social media access alone fails to equip children for healthy use of technology, argues a group of international experts in The BMJ today.

27 Mar 2025

New AI method could predict emerging SARS-CoV-2 variants

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain.

27 Mar 2025

Machine learning model outperforms traditional methods in myelofibrosis risk stratification

A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) outperformed standard statistical models in identifying and stratifying transplant risk for patients with myelofibrosis, according to new research published today in Blood, the American Society of Hematology's flagship journal.

27 Mar 2025

Enhancing the value of virtual care through strategic partnerships

Recent analysis by the National Health Institute indicates that telehealth now accounts for 23% of all health care encounters nationwide, with some clinical specialties reporting virtual visit rates now exceeding 50%.

27 Mar 2025

Study uncovers surprising role for calcium in shaping life's earliest molecular structures

A new study led by researchers at the Earth-Life Science Institute (ELSI) at Institute of Science Tokyo has uncovered a surprising role for calcium in shaping life's earliest molecular structures.

27 Mar 2025

Novel insights into tumor microenvironment and gastric cancer therapy

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one of the deadliest cancers worldwide. By using advanced mapping technologies, they created a detailed "atlas" of stomach tumors, revealing hidden patterns in how cancer cells behave, evolve and interact with their environment. These insights could lead to more precise, targeted treatments that improve survival rates and reduce side effects.

27 Mar 2025

Diagnostic colonoscopy follow-up unaffected by COVID-19 surge, despite screening delays

Two recent studies by researchers from Regenstrief Institute and the Indiana University School of Medicine explore the effect of the pandemic on colorectal cancer screening tests and diagnostic colonoscopies in Central Indiana. The findings of temporary disruption to the former and minimal impact on the latter are similar to findings across the U.S., contributing to the compendium of knowledge on preventive health uptake and subsequent treatment in various populations during the pandemic.

27 Mar 2025

Education News and Research

WARRIOR trial finds no impact of intensive therapy on heart events in women

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Study finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery

Research reveals optimal duration of dual antiplatelet therapy after stent implantation

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Rivaroxaban shown to be a viable alternative to warfarin for left ventricular thrombus

The Giants Foundation and American Heart Association promote life-saving CPR skills

UTA expert discusses the latest developments of measles outbreak in Texas

A briefing on the impact of obesity in older populations

Discrimination exposure found to raise anxiety, depression risks among racial and ethnic groups

Interval cancers account for significant breast cancer cases

Expanded access to anti-obesity medications could boost life expectancy and save society billions

Banning smartphone and social media access fails to protect children from digital harm

New AI method could predict emerging SARS-CoV-2 variants

Machine learning model outperforms traditional methods in myelofibrosis risk stratification

Enhancing the value of virtual care through strategic partnerships

Study uncovers surprising role for calcium in shaping life's earliest molecular structures

Novel insights into tumor microenvironment and gastric cancer therapy

Diagnostic colonoscopy follow-up unaffected by COVID-19 surge, despite screening delays

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo